These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35187881)

  • 21. Partial heterologous protection by low pathogenic H9N2 virus against natural H9N2-PB1 gene reassortant highly pathogenic H5N1 virus in chickens.
    Dash SK; Kumar M; Kataria JM; Nagarajan S; Tosh C; Murugkar HV; Kulkarni DD
    Microb Pathog; 2016 Jun; 95():157-165. PubMed ID: 27057675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insertion of Basic Amino Acids in the Hemagglutinin Cleavage Site of H4N2 Avian Influenza Virus (AIV)-Reduced Virus Fitness in Chickens is Restored by Reassortment with Highly Pathogenic H5N1 AIV.
    Gischke M; Ulrich R; I Fatola O; Scheibner D; Salaheldin AH; Crossley B; Böttcher-Friebertshäuser E; Veits J; Mettenleiter TC; Abdelwhab EM
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.
    McKimm-Breschkin JL; Barrett S; Wong FYK; Pudjiatmoko ; Azhar M; Selleck P; Davies KR; Hartaningsih N; McGrane J
    Antiviral Res; 2018 May; 153():95-100. PubMed ID: 29574145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
    Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostimulatory motifs enhance antiviral siRNAs targeting highly pathogenic avian influenza H5N1.
    Stewart CR; Karpala AJ; Lowther S; Lowenthal JW; Bean AG
    PLoS One; 2011; 6(7):e21552. PubMed ID: 21747939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Compatibility of Reassortants between Avian H5N1 and H9N2 Influenza Viruses with Higher Pathogenicity in Mammals.
    Arai Y; Ibrahim MS; Elgendy EM; Daidoji T; Ono T; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
    Panaampon J; Ngaosuwankul N; Suptawiwat O; Noisumdaeng P; Sangsiriwut K; Siridechadilok B; Lerdsamran H; Auewarakul P; Pooruk P; Puthavathana P
    PLoS One; 2012; 7(5):e36318. PubMed ID: 22563489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human microRNA-24 modulates highly pathogenic avian-origin H5N1 influenza A virus infection in A549 cells by targeting secretory pathway furin.
    Loveday EK; Diederich S; Pasick J; Jean F
    J Gen Virol; 2015 Jan; 96(Pt 1):30-39. PubMed ID: 25234642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
    Rajesh Kumar S; Chelvaretnam S; Tan Y; Prabakaran M
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29295514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
    Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.
    Bertran K; Thomas C; Guo X; Bublot M; Pritchard N; Regan JT; Cox KM; Gasdaska JR; Dickey LF; Kapczynski DR; Swayne DE
    Vaccine; 2015 Jul; 33(30):3456-62. PubMed ID: 26067184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nucleoprotein and matrix protein segments of H5N1 influenza viruses are responsible for dominance in embryonated eggs.
    Shimizu K; Li C; Muramoto Y; Yamada S; Arikawa J; Chen H; Kawaoka Y
    J Gen Virol; 2011 Jul; 92(Pt 7):1645-1649. PubMed ID: 21471324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
    Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
    Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential.
    Spieler EE; Moritz E; Stertz S; Hale BG
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32848003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H5N1 NS genomic segment distinctly governs the influenza virus infectivity and cytokine induction in monocytic cells.
    Lamichhane PP; Boonnak K; Changsom D; Noisumdaeng P; Sangsiriwut K; Pattanakitsakul SN; Puthavathana P
    Asian Pac J Allergy Immunol; 2018 Mar; 36(1):58-68. PubMed ID: 28802028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic characterization of H5N1 influenza viruses isolated from chickens in Indonesia in 2010.
    Nidom CA; Yamada S; Nidom RV; Rahmawati K; Alamudi MY; Kholik ; Indrasari S; Hayati RS; Iwatsuki Horimoto K; Kawaoka Y
    Virus Genes; 2012 Jun; 44(3):459-65. PubMed ID: 22323117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin.
    Stoppani E; Bassi I; Dotti S; Lizier M; Ferrari M; Lucchini F
    Antiviral Res; 2015 Aug; 120():16-22. PubMed ID: 25986248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-Treatment with Zirconia Nanoparticles Reduces Inflammation Induced by the Pathogenic H5N1 Influenza Virus.
    Huo C; Xiao J; Xiao K; Zou S; Wang M; Qi P; Liu T; Hu Y
    Int J Nanomedicine; 2020; 15():661-674. PubMed ID: 32099358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.